Leonard Baker Jr Net Worth & Insider Trades
Leonard Baker Jr - Director, Corcept Therapeutics Inc
What is Leonard Baker Jr's Net Worth?
The current estimated net worth of Corcept Therapeutics Inc's Director, Leonard Baker Jr, is estimated to be about $32.68M . Leonard Baker Jr owns about 4,263,358 units of Corcept Therapeutics Inc common stock. In the last 19 years at Corcept Therapeutics Inc, Leonard Baker Jr has sold an estimated value of $3.61M worth.
What is Leonard Baker Jr's Past Insider Trading?
Leonard Baker Jr's largest purchase order was 150,000 units , worth over $3.23M on June 15, 2021. Leonard Baker Jr's largest sale order was 314,356 units , worth over $1.84M on March 24, 2015. In total, Leonard Baker Jr has made about 62 transactions over 19 years of their time at Corcept Therapeutics Inc. Leonard Baker Jr usually trades in November, with the busiest year in 2020.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
LEONARD BAKER JR
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Leonard Baker Jr's' Mailing Address?
- Mailing address is 755 Page Mill Road, Suite A-200 Palo Alto CA 94304-1005 CA
Corcept Therapeutics Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Option Awards
|
Other Compensation
|
Total
|
---|---|---|---|---|---|---|
Joseph K. Belanoff, M.D., | 2020 | $769,567 | $744,000 | $4,237,643 | $10,892 | $5,762,102 |
Joseph K. Belanoff, M.D., | 2019 | $707,525 | $745,290 | $3,506,155 | - | $4,958,970 |
Joseph K. Belanoff, M.D., | 2018 | $679,792 | $477,750 | $5,157,075 | - | $6,314,617 |
Andreas Grauer, M.D., | 2020 | $454,550 | $219,157 | $1,271,293 | $118,274 | $2,063,274 |
Andreas Grauer, M.D., | 2019 | $362,267 | $243,720 | $3,115,335 | $78,245 | $3,799,567 |
Hazel Hunt, Ph.D., | 2020 | $431,873 | $243,000 | $2,084,640 | - | $2,759,513 |
Sean Maduck, | 2020 | $474,380 | $214,157 | $2,508,404 | - | $3,196,941 |
Sean Maduck, | 2019 | $456,133 | $308,881 | $1,476,276 | - | $2,241,290 |
Sean Maduck, | 2018 | $436,667 | $198,000 | $2,171,400 | - | $2,806,067 |
Charles Robb, | 2020 | $474,380 | $321,236 | $2,118,822 | - | $2,914,438 |
Charles Robb, | 2019 | $456,133 | $308,881 | $1,845,345 | - | $2,610,359 |
Charles Robb, | 2018 | $436,667 | $237,600 | $2,171,400 | - | $2,845,667 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1088856/000162828021007363/a2021def14a.htm
What are Corcept Therapeutics Inc's Past Insider Trades?
Corcept Therapeutics Inc's most recent insider trade came on November 3, 2023 by Joseph Douglas Lyon who sold 5,000 units worth $140.52K . In the last 19 years, insiders at Corcept Therapeutics Inc have sold an estimated value of $205.7M and bought an estimated value of $188.56M worth of shares. Insider trading is most common in February, with the busiest year in 2006. The most active traders at the company are Joseph K Belanoff, Chief Executive Officer, Robert Roe, President and Secretary, and Leonard Baker Jr, Director .
CORCEPT THERAPEUTICS INC Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |